alcon

Novartis Spending $39 Billion for Alcon

Switzerland's Novartis said Monday it will spend about $39 billion in a two-step bid for a majority stake in U.S. eye-care company Alcon.

The deal for Alcon Inc., which makes Opti-Free contact lens solution and has 14,500 employees worldwide, would be one of the largest in Swiss history.

Vested Interest: 
None listed
Stock Symbol: NVS NOVARTIS AG ADS Stock Price: $53.38 Todays Change: +0.04 (+0.07%)